646 related articles for article (PubMed ID: 16735678)
41. Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection.
Szabó G; Bährle S; Sivanandam V; Stumpf N; Gerö D; Berger I; Beller C; Hagl S; Szabó C; Dengler TJ
J Heart Lung Transplant; 2006 Jul; 25(7):794-804. PubMed ID: 16818122
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
Kimura N; Itoh S; Nakae S; Axtell RC; Velotta JB; Bos EJ; Merk DR; Gong Y; Okamura H; Nagamine CM; Adachi H; Kornfeld H; Robbins RC; Fischbein MP
J Heart Lung Transplant; 2011 Dec; 30(12):1409-17. PubMed ID: 22055099
[TBL] [Abstract][Full Text] [Related]
43. [Expression of non-T cell derived cytokines in acute rejection after heart transplantation: experiment with mouse model].
Liang TB; Yu ZY; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):26-30. PubMed ID: 16606531
[TBL] [Abstract][Full Text] [Related]
44. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
45. Inactivation of T-cell receptor-mediated integrin activation prolongs allograft survival in ADAP-deficient mice.
Tian J; Pabst O; Römermann D; Skubich S; Förster R; Beckmann J; Chen JH; Hoffmann MW
Transplantation; 2007 Aug; 84(3):400-6. PubMed ID: 17700167
[TBL] [Abstract][Full Text] [Related]
46. Analysis of cytokine functions in graft rejection by gene expression profiles.
Liang Y; Christopher K; DeFina R; Cidado J; He H; Haley KJ; Finn PW; Perkins DL
Transplantation; 2003 Dec; 76(12):1749-58. PubMed ID: 14688527
[TBL] [Abstract][Full Text] [Related]
47. Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation.
Iwanaga K; Hasegawa T; Hultquist DE; Harada H; Yoshikawa Y; Yanamadala S; Liao H; Visovatti SH; Pinsky DJ
Transplantation; 2007 Mar; 83(6):747-53. PubMed ID: 17414708
[TBL] [Abstract][Full Text] [Related]
48. Induction of indefinite survival of fully mismatched cardiac allografts and generation of regulatory cells by sarpogrelate hydrochloride.
Akiyoshi T; Zhang Q; Inoue F; Aramaki O; Hatano M; Shimazu M; Kitajima M; Shirasugi N; Niimi M
Transplantation; 2006 Oct; 82(8):1051-9. PubMed ID: 17060854
[TBL] [Abstract][Full Text] [Related]
49. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
Chen Y; Liu Y; Yuan Z; Tian L; Dallman MJ; Thompson PW; Tam PK; Lamb JR
Transplantation; 2007 Jun; 83(12):1602-10. PubMed ID: 17589344
[TBL] [Abstract][Full Text] [Related]
50. Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft.
Hüser N; Fasan A; Semmrich M; Schmidbauer P; Holzmann B; Laschinger M
Int Immunol; 2010 Jan; 22(1):35-44. PubMed ID: 19946016
[TBL] [Abstract][Full Text] [Related]
51. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
[TBL] [Abstract][Full Text] [Related]
54. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
55. Role of selectin-dependent adhesion in cardiac allograft rejection.
Yamazaki S; Isobe M; Suzuki J; Tojo S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1998 Oct; 17(10):1007-16. PubMed ID: 9811410
[TBL] [Abstract][Full Text] [Related]
56. Artemisiae capillaris herba induces prolonged survival of fully cardiac allografts and generates regulatory cells in mice.
Jin X; Uchiyama M; Zhang Q; Watanabe T; Niimi M
Transplant Proc; 2012 May; 44(4):1073-5. PubMed ID: 22564628
[TBL] [Abstract][Full Text] [Related]
57. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
58. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
Saiura A; Sata M; Hiasa K; Kitamoto S; Washida M; Egashira K; Nagai R; Makuuchi M
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1886-90. PubMed ID: 15284091
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
[TBL] [Abstract][Full Text] [Related]
60. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts.
Suzuki J; Morishita R; Amano J; Kaneda Y; Isobe M
Gene Ther; 2000 Nov; 7(21):1847-52. PubMed ID: 11110417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
